Company intelligence / Profile preview

IsoAid

Port Richey, Florida, United States

Ownership: Private
Employees: ~32
Development stage: Other

Overview

IsoAid's brachytherapy seeds (I-125 and Pd-103) are FDA-cleared and used in the commercial setting for prostate, ocular, and diagnostic breast applications. Products comply with ISO 13485 and AAPM/RPC standards and are widely used in established clinical practice.[1][4][5]

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalDevice
Industry: Implantable Medical Devices

Partnerships

Eye Physics, LLC

Beyond the preview

Go deeper on IsoAid.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IsoAid.

Explore the full profile